期刊文献+

地尔硫卓治疗老年重症高血压的疗效分析 被引量:5

Analyses of the therapeutic effect of Diltiazem Infusion in Patients with grave hypertension
下载PDF
导出
摘要 目的观察地尔硫卓治疗老年重症高血压的临床疗效。方法对2010年1月~2011年1月收治的78例老年重症高血压患者,按随机数字表法分为:对照组38例给予阿托伐他汀治疗,观察组40例,在对照组治疗的基础上加用地尔硫卓治疗。两组均以21d为一个疗程。比较两组的临床疗效、不良反应发生率情况。结果观察组总有效率为92.5%(37/40),对照组总有效率为86.8%(33/38),两组总有效率在统计学上具有显著差异(P<0.05)。两组治疗期间不良反应发生率为观察组7.5%(3/40),对照组7.9%(3/38),但未出现严重不良反应。结论地尔硫卓治疗老年重症高血压疗效确切,安全性好,值得临床推广应用。 Objective To analyze the therapeutic effect of Diltiazem Infusion in Patients with grave hypertension. Methods We analyzed 78 eases who had grave hypertension in our department from January 2010 to January 2012,78 cases were randomly divided into 2 groups of 38 cases in experimental group who had given atorvastatin calcium, and 40 cases in the control group who had given atorvastatin calcium and Diltiazem. Contrast the total effective, and complication.Results The total effective rates were 92.5%(37/40) ,86.8%(33/38) (P〈0.05). (3) The complication incident rates were 7.5% (3/40) and 7.9% (3/38) of significant differences in groups(P〈0. 05). Conclusion It is significant effective that Diltiazem to grave hypertenSion. It is safe and should widely be used in patients with these diseases.
出处 《西部医学》 2013年第4期536-537,共2页 Medical Journal of West China
关键词 重症高血压 老龄 地尔硫卓 疗效 Grave hypertension Old ages Diltiazem Therapeutic effect
  • 相关文献

参考文献11

二级参考文献38

  • 1张勇,曾小鸿.血脂紊乱和调血脂药的合理应用[J].中国药师,2005,8(6):510-512. 被引量:6
  • 2刘振东,路方红,赵颖馨,金世宽,闫志晖,刘军,孙尚文.高龄老年高血压病患者动态血压与左心室肥厚关系的研究[J].中华老年心脑血管病杂志,2006,8(3):216-216. 被引量:8
  • 3龚培力.抗高血压药物的评价与研究进展[J].医药导报,2007,26(4):334-339. 被引量:62
  • 4Levy D, Garrison R J, Savage DD, et al. Prognostic implications of echocardiographicaly determined left ventricular mass in the Fram-ingham Heart Study[J]. N Engl J Med, 1990,322:1561-1566.
  • 5O'rourke RA. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on recommendation for standardization of measurements from M-mode echo-cardiograms [ J ]. Circulation, 1984,69:854A.
  • 6Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiograpby, anatomic validations, sdandardization, and comparison to other methods [ J]. Hypertension, 1987,9 ( suppl Ⅱ ) : 19 -26.
  • 7Verdecchia P, Schiuacil L, Gatteschic C, et al. Blunted no tarnal fall in blood pressure in hypertension with future cardiovascular morbid events[ J]. Circulation, 1983, 88:986.
  • 8Casale PN, Devereux RB, Milener M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive man [ J]. Ann Intern Med, 1986,105 : 173.
  • 9Verdecchia P, Schillci G, Boldrini F, et al. Risk stratification of left ventricular hypertrophy in systemic hypertension using moninvasive ambulatory, blood pressure monitoring[ J]. Am J Cardiol, 1990,66:583.
  • 10中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订本全文).高血压杂志,2005,8(2):94-102.

共引文献113

同被引文献32

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部